APA

Guo W., Liu R., Bhardwaj G., Ma A., Changou C., Yang J. C., Li Y., Feng C., Luo Y., Mazloom A., Sanchez E., Wang Y., Huang W., Patterson R., Evans C. P., Lam K. S. & Kung H. (20140923). CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitors. : PloS one.

Chicago

Guo Wenchang, Liu Ruiwu, Bhardwaj Gaurav, Ma Ai-Hong, Changou Chun, Yang Joy C, Li Yuanpei, Feng Caihong, Luo Yan, Mazloom Anisha, Sanchez Eduardo, Wang Yan, Huang Wenzhe, Patterson Randen, Evans Christopher P, Lam Kit S and Kung Hsing-Jien. 20140923. CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitors. : PloS one.

Harvard

Guo W., Liu R., Bhardwaj G., Ma A., Changou C., Yang J. C., Li Y., Feng C., Luo Y., Mazloom A., Sanchez E., Wang Y., Huang W., Patterson R., Evans C. P., Lam K. S. and Kung H. (20140923). CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitors. : PloS one.

MLA

Guo Wenchang, Liu Ruiwu, Bhardwaj Gaurav, Ma Ai-Hong, Changou Chun, Yang Joy C, Li Yuanpei, Feng Caihong, Luo Yan, Mazloom Anisha, Sanchez Eduardo, Wang Yan, Huang Wenzhe, Patterson Randen, Evans Christopher P, Lam Kit S and Kung Hsing-Jien. CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitors. : PloS one. 20140923.